Cognex Corp: Form 10-Q for the period ended Jul 3, 2022
Filed with the SEC on Aug 2, 2022 and accepted by EDGAR at Aug 2, 2022, 16:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-07-03. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-04-04 to 2022-07-03 | $274.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2022-01-01 to 2022-07-03 | $557.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-04-04 to 2022-07-03 | $78.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2022-01-01 to 2022-07-03 | $156.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-04-04 to 2022-07-03 | $196.5m | us-gaap:GrossProfit |
| Gross profit | 6 months2022-01-01 to 2022-07-03 | $400.1m | us-gaap:GrossProfit |
| Research and development | 3 months2022-04-04 to 2022-07-03 | $34.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2022-01-01 to 2022-07-03 | $70.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-04-04 to 2022-07-03 | $80.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-01-01 to 2022-07-03 | $160.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-04-04 to 2022-07-03 | $65.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-01-01 to 2022-07-03 | $151.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-04-04 to 2022-07-03 | $5.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-01-01 to 2022-07-03 | $25.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-04-04 to 2022-07-03 | $58.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-01-01 to 2022-07-03 | $126.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-04-04 to 2022-07-03 | $0.34 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-01-01 to 2022-07-03 | $0.72 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months2022-04-04 to 2022-07-03 | 174,993,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-01-01 to 2022-07-03 | 175,874,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-01-01 to 2022-07-03 | $93.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-01-01 to 2022-07-03 | $11.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2022-01-01 to 2022-07-03 | $22.6m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2022-01-01 to 2022-07-03 | $154.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-07-03 | $177.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-07-03 | $734.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-07-03 | $1.94bn | us-gaap:Assets |
| Current liabilities | At period end2022-07-03 | $192.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-07-03 | $553.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-07-03 | $1.39bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2022-07-03 | 173,396,962 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000851205-22-000019. Last ingested by Listed: Nov 10, 2026, 23:02 ET. Listed shows no prices and gives no investment advice.